United Kingdom· GB-APID-39494311000001109
Leqvio 284mg/1.5ml solution for injection pre-filled syringes
A inclisiran product containing inclisiran, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Inclisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AX16 (inclisiran), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Inclisiran · ATC C10AX16
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Inclisiran
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- C10AX16
- ATC class
- Inclisiran
- Defined daily dose
- 1.6 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07613421044237
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inclisiran in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLEQVIO 284 mg SOLUCION INYECTABLE EN JERINGA PRECARGADANovartis Europharm Limited
- NorwayLeqvioNovartis Europharm Limited
- IcelandLeqvioNovartis Europharm Limited*
- ItalyLEQVIO*1 siringa preriempita SC 1,5 ml 284 mg 189 mg/ml con dispositivo di protezione dell'agoNOVARTIS EUROPHARM LTD
- NetherlandsLeqvio 284 mg oplossing voor injectie in een voorgevulde spuitNovartis Europharm Limited
- PolandLeqvioNovartis Europharm Limited
- CanadaLEQVIONOVARTIS PHARMACEUTICALS CANADA INC
- SwedenLeqvio 284 mg Injektionsvätska, lösning i förfylld sprutaNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Leqvio
- Liechtenstein · Leqvio
- Norway · Leqvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c55b1f6d-fdc0-48b6-bba2-a1625b5e7484 GET /v1/drugs/c55b1f6d-fdc0-48b6-bba2-a1625b5e7484?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39494311000001109",
"desc": "Leqvio 284mg/1.5ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd)",
"form": "Solution for injection",
"vpid": "39495111000001106",
"source": "dmd",
"vtm_id": "1306561008",
"strength": "189 mg",
"substance": "Inclisiran",
"ingredient": "Inclisiran sodium",
"supplier_code": "2920101000001102"
}See everything about inclisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.